Journal
SCHIZOPHRENIA RESEARCH
Volume 83, Issue 2-3, Pages 185-192Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.schres.2006.01.010
Keywords
(genetic) polymorphism; extrapyramidal (syndrome/disorder); tardive dyskinesia; drug-induced; antipsychotic; dopamine 3 receptor
Categories
Ask authors/readers for more resources
Background: A polymorphic site in the gene encoding the dopamine 3 receptor (DRD3) resulting in a serine (Set) into glycine (Gly) substitution has been shown to affect dopamine binding affinity, and may contribute to individual differences in susceptibility to antipsychotic-induced tardive dyskinesia (TD). Methods: A Medline, EMBASE and PsychINFO search of literature published between 1976 and March 2005 yielded 11 studies from which data were extracted for calculation of pooled estimates using meta-analytic techniques. Results: The Gly allele increased the risk relative to the Ser allele (OR = 1.17; 95% CI: 1.01-1.37) with evidence of publication bias. No significant genotype effects were apparent. Conclusions: TD may be associated with functional variation in the DRD3 allele. However, caution is required in interpreting this finding, as there is evidence of publication bias, genetic methodology has shortcomings, and the relation between antipsychotics, schizophrenia and TD is complex. (c) 2006 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available